Skip to main content
FRMSP logo

FRMSP — Investor Relations & Filings

Ticker · 6838 ISIN · TW0006838006 TW Professional, scientific and technical activities
Open in API
Filings indexed 30 across all filing types
Latest filing 2026-05-12 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 6838

About FRMSP

www.formosapharma.com

Formosa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company specializing in the development of innovative therapies within the fields of ophthalmology, oncology, and anti-infectives. The company utilizes its proprietary Activus Pure Nano-technology (APNT®) platform to enhance the formulation of poorly soluble drugs, improving bioavailability and efficacy. Its lead product, APP13007, is a clobetasol propionate ophthalmic suspension developed for the treatment of post-operative inflammation and pain following ocular surgery, which has received regulatory approval in the United States. Formosa Pharmaceuticals focuses on the 505(b)(2) regulatory pathway and the development of antibody-drug conjugates (ADCs). The company actively pursues global licensing and co-development partnerships to advance its pipeline of high-value therapeutic assets.

Recent filings

Filing Released Lang Actions
115年第1季海外子公司投資
Interim / Quarterly Report Classification · 78% confidence The document is titled “115年1季申報作業” (Q1 submission) on Taiwan’s public information platform and provides actual financial data (investment balances, equity share, P&L recognized) for the reporting quarter. This is substantive quarterly financial information rather than merely announcing or linking to a report, satisfying the criteria for an Interim/Quarterly Report. Q1 2026
2026-05-12 Chinese
115年第1季財務報告書 — 202601_6838_AI1.pdf
Interim / Quarterly Report Classification · 92% confidence The document is titled “合併財務報告暨會計師核閱報告 民國115年及114年第一季” and contains full interim consolidated financial statements (balance sheet, income statement, cash flows, equity changes, extensive notes) plus the auditor’s review report. It is a detailed quarterly (first‐quarter) report with actual financial data prepared under IFRS 34, not merely an announcement or a short notice. This matches the definition of an Interim/Quarterly Report (IR), not an Annual Report or simple audit certificate. Q1 2026
2026-05-12 Chinese
115年第1季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document is the consolidated statement of changes in equity for Q1 (115th year, ROC calendar), showing detailed interim financial data (beginning balances, net profit, other comprehensive income, ending balances). It is substantive financial information for a period shorter than a full fiscal year, not merely an announcement or reference to a report. Therefore, it is classified as an Interim / Quarterly Report (IR). Q1 2026
2026-05-11 Chinese
115年第1季現金流量表
Regulatory Filings Classification · 10% confidence The document text is an error/security message indicating the page cannot be accessed, with no financial content or reference to any filing type. It does not match any specific filing category definitions, so it falls into the fallback category of miscellaneous regulatory announcements.
2026-05-11 Chinese
115年第1季綜合損益表
Interim / Quarterly Report Classification · 88% confidence The document is a detailed consolidated income statement (合併綜合損益表) for the first quarter of fiscal year 115 (民國115年第1季), with actual line-by-line financial amounts and percentages. It is not merely an announcement or link to a report; it contains substantive financial data for the quarter. This fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-05-11 Chinese
115年第1季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document is the consolidated balance sheet for the first quarter of 民國115年 (Q1 interim period), providing detailed financial statement line items and comparative figures to year-end and prior year quarter. It contains substantive financial data rather than merely announcing or referencing a report, which fits an interim/quarterly report filing. Q1 2026
2026-05-11 Chinese

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.